Trial Outcomes & Findings for US PRECISION Implementation Study (NCT NCT04891978)

NCT ID: NCT04891978

Last Updated: 2025-07-08

Results Overview

The post-study HCP survey includes questions regarding the implementation of the PRECISION program (e.g., how would you rate the overall ease of implementing the AIRQ into your clinical practice using the telehealth platform?)

• Recruitment status: COMPLETED
• Study phase: NA
• Target enrollment: 857 participants
• Primary outcome timeframe: Post-study survey was completed between 5 weeks and 50.6 weeks of last patient end of follow-up across sites; end of follow up was 36 weeks from last patient enrolled at site (or 6 weeks for the novel care site).
• Results posted on: 2025-07-08

Participant Flow

Thirteen sites in the US were selected (6 primary care, 6 specialty care, 1 novel site) to implement the PRECISION program. Clinic staff invited patients ≥13 years old with HCP-confirmed asthma diagnosis who were presenting for a telehealth or in-person visit to complete the AIRQ. Each primary and specialty site aimed to recruit approximately 50 patients, up to 100 maximum. The novel site aimed to recruit 150 patients. Patients were recruited between April 2021 and February 2022.

Unit of analysis: Sites

Participant milestones

Measure	Primary Care Sites e.g., private practice, FQHC	Specialty Care Sites e.g., pulmonary, asthma/immunology	Novel Site e.g., telehealth component of Allergy and Asthma Network
Baseline STARTED	434 6	281 6	142 1
Baseline COMPLETED	431 6	280 6	133 1
Baseline NOT COMPLETED	3 0	1 0	9 0
Follow-up STARTED	431 6	280 6	133 1
Follow-up COMPLETED	145 4	100 5	126 1
Follow-up NOT COMPLETED	286 2	180 1	7 0

Reasons for withdrawal

Measure	Primary Care Sites e.g., private practice, FQHC	Specialty Care Sites e.g., pulmonary, asthma/immunology	Novel Site e.g., telehealth component of Allergy and Asthma Network
Baseline Protocol Violation	2	1	0
Baseline Missing AIRQ	1	0	0
Baseline Did not attend a baseline visit	0	0	9

Baseline Characteristics

US PRECISION Implementation Study

Baseline characteristics by cohort

Measure	Primary Care Sites n=6 Sites e.g., private practice, FQHC	Specialty Care Sites n=6 Sites e.g., pulmonary, asthma/immunology	Novel Site n=1 Sites e.g., telehealth component of Allergy and Asthma Network	Total n=13 Sites Total of all reporting groups
Age, Continuous	46.5 Years STANDARD_DEVIATION 18.8 • n=5 Participants	46.9 Years STANDARD_DEVIATION 19.0 • n=7 Participants	38.9 Years STANDARD_DEVIATION 14.2 • n=5 Participants	45.4 Years STANDARD_DEVIATION 18.4 • n=4 Participants
Sex/Gender, Customized Female	296 Participants n=5 Participants	202 Participants n=7 Participants	95 Participants n=5 Participants	593 Participants n=4 Participants
Sex/Gender, Customized Male	134 Participants n=5 Participants	77 Participants n=7 Participants	38 Participants n=5 Participants	249 Participants n=4 Participants
Sex/Gender, Customized Other/non-binary	1 Participants n=5 Participants	1 Participants n=7 Participants	0 Participants n=5 Participants	2 Participants n=4 Participants
Ethnicity (NIH/OMB) Hispanic or Latino	91 Participants n=5 Participants	14 Participants n=7 Participants	1 Participants n=5 Participants	106 Participants n=4 Participants
Ethnicity (NIH/OMB) Not Hispanic or Latino	302 Participants n=5 Participants	251 Participants n=7 Participants	8 Participants n=5 Participants	561 Participants n=4 Participants
Ethnicity (NIH/OMB) Unknown or Not Reported	38 Participants n=5 Participants	15 Participants n=7 Participants	124 Participants n=5 Participants	177 Participants n=4 Participants
Race (NIH/OMB) American Indian or Alaska Native	2 Participants n=5 Participants	1 Participants n=7 Participants	0 Participants n=5 Participants	3 Participants n=4 Participants
Race (NIH/OMB) Asian	57 Participants n=5 Participants	4 Participants n=7 Participants	0 Participants n=5 Participants	61 Participants n=4 Participants
Race (NIH/OMB) Native Hawaiian or Other Pacific Islander	3 Participants n=5 Participants	1 Participants n=7 Participants	0 Participants n=5 Participants	4 Participants n=4 Participants
Race (NIH/OMB) Black or African American	75 Participants n=5 Participants	42 Participants n=7 Participants	2 Participants n=5 Participants	119 Participants n=4 Participants
Race (NIH/OMB) White	254 Participants n=5 Participants	217 Participants n=7 Participants	7 Participants n=5 Participants	478 Participants n=4 Participants
Race (NIH/OMB) More than one race	0 Participants n=5 Participants	0 Participants n=7 Participants	0 Participants n=5 Participants	0 Participants n=4 Participants
Race (NIH/OMB) Unknown or Not Reported	40 Participants n=5 Participants	15 Participants n=7 Participants	124 Participants n=5 Participants	179 Participants n=4 Participants
Clinician's rating of patient's asthma severity Intermittent	206 Participants n=5 Participants	30 Participants n=7 Participants	42 Participants n=5 Participants	278 Participants n=4 Participants
Clinician's rating of patient's asthma severity Mild persistent	100 Participants n=5 Participants	61 Participants n=7 Participants	23 Participants n=5 Participants	184 Participants n=4 Participants
Clinician's rating of patient's asthma severity Moderate persistent	112 Participants n=5 Participants	117 Participants n=7 Participants	43 Participants n=5 Participants	272 Participants n=4 Participants
Clinician's rating of patient's asthma severity Severe persistent	13 Participants n=5 Participants	71 Participants n=7 Participants	25 Participants n=5 Participants	109 Participants n=4 Participants
Clinician's rating of patient's asthma severity Missing	0 Participants n=5 Participants	1 Participants n=7 Participants	0 Participants n=5 Participants	1 Participants n=4 Participants
AIRQ Control Categories Well controlled (0-1)	214 Participants n=5 Participants	121 Participants n=7 Participants	23 Participants n=5 Participants	358 Participants n=4 Participants
AIRQ Control Categories Not well controlled (2-4)	144 Participants n=5 Participants	80 Participants n=7 Participants	41 Participants n=5 Participants	265 Participants n=4 Participants
AIRQ Control Categories Very poorly controlled (5-10)	73 Participants n=5 Participants	79 Participants n=7 Participants	69 Participants n=5 Participants	221 Participants n=4 Participants

PRIMARY outcome

Timeframe: Post-study survey was completed between 5 weeks and 50.6 weeks of last patient end of follow-up across sites; end of follow up was 36 weeks from last patient enrolled at site (or 6 weeks for the novel care site).

Population: Number of site HCPs who responded to the post-study HCP survey (one HCP responded per site)

The post-study HCP survey includes questions regarding the implementation of the PRECISION program (e.g., how would you rate the overall ease of implementing the AIRQ into your clinical practice using the telehealth platform?)

Outcome measures

Measure	Primary Care Sites n=6 Sites e.g., private practice, FQHC	Specialty Care Sites n=6 Sites e.g., pulmonary, asthma/immunology	Novelty Care Site n=1 Sites e.g., telehealth component of Allergy and Asthma Network	Total n=13 Sites All sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Overall Ease of Implementing AIRQ Into Clinical Practice. Overall ease of implementing AIRQ into clinical practice using telehealth platform · Very easy	1 Sites	3 Sites	1 Sites	5 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Overall Ease of Implementing AIRQ Into Clinical Practice. Overall ease of implementing AIRQ into clinical practice using telehealth platform · Somewhat easy	4 Sites	2 Sites	0 Sites	6 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Overall Ease of Implementing AIRQ Into Clinical Practice. Overall ease of implementing AIRQ into clinical practice using telehealth platform · Difficult	0 Sites	1 Sites	0 Sites	1 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Overall Ease of Implementing AIRQ Into Clinical Practice. Overall ease of implementing AIRQ into clinical practice using telehealth platform · Very Difficult	0 Sites	0 Sites	0 Sites	0 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Overall Ease of Implementing AIRQ Into Clinical Practice. Overall ease of implementing AIRQ into clinical practice using telehealth platform · Missing	1 Sites	0 Sites	0 Sites	1 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Overall Ease of Implementing AIRQ Into Clinical Practice. Overall ease of implementing AIRQ into clinical practice during an in-person visit · Very easy	3 Sites	5 Sites	0 Sites	8 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Overall Ease of Implementing AIRQ Into Clinical Practice. Overall ease of implementing AIRQ into clinical practice during an in-person visit · Somewhat easy	3 Sites	1 Sites	0 Sites	4 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Overall Ease of Implementing AIRQ Into Clinical Practice. Overall ease of implementing AIRQ into clinical practice during an in-person visit · Difficult	0 Sites	0 Sites	0 Sites	0 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Overall Ease of Implementing AIRQ Into Clinical Practice. Overall ease of implementing AIRQ into clinical practice during an in-person visit · Very Difficult	0 Sites	0 Sites	0 Sites	0 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Overall Ease of Implementing AIRQ Into Clinical Practice. Overall ease of implementing AIRQ into clinical practice during an in-person visit · Missing	0 Sites	0 Sites	1 Sites	1 Sites

PRIMARY outcome

Timeframe: Post-study survey was completed between 5 weeks and 50.6 weeks of last patient end of follow-up across sites; end of follow up was 36 weeks from last patient enrolled at site (or 6 weeks for the novel care site).

Population: Number of site HCPs who responded to the post-study HCP survey (one HCP responded per site)

The post-study HCP survey includes questions regarding the implementation of the PRECISION program at the site (e.g., Did AIRQ help you manage your patients?)

Outcome measures

Measure	Primary Care Sites n=6 Sites e.g., private practice, FQHC	Specialty Care Sites n=6 Sites e.g., pulmonary, asthma/immunology	Novelty Care Site n=1 Sites e.g., telehealth component of Allergy and Asthma Network	Total n=13 Sites All sites
Percentage Endorsement of Responses by Site HCPs for the Categorical Item on the Post-study Survey Relating to How Much the AIRQ Helped Manage Patients Yes very much	5 Sites	0 Sites	0 Sites	5 Sites
Percentage Endorsement of Responses by Site HCPs for the Categorical Item on the Post-study Survey Relating to How Much the AIRQ Helped Manage Patients Yes somewhat	1 Sites	5 Sites	1 Sites	7 Sites
Percentage Endorsement of Responses by Site HCPs for the Categorical Item on the Post-study Survey Relating to How Much the AIRQ Helped Manage Patients Not at all	0 Sites	1 Sites	0 Sites	1 Sites

PRIMARY outcome

Timeframe: Post-study survey was completed between 5 weeks and 50.6 weeks of last patient end of follow-up across sites; end of follow up was 36 weeks from last patient enrolled at site (or 6 weeks for the novel care site).

Population: Number of site HCPs who responded to the post-study HCP survey (one HCP responded per site)

The post-study HCP survey includes questions regarding the implementation of the PRECISION program at the site (e.g., Did AIRQ help you identify patients who were at risk for adverse health outcomes from their asthma that you would have otherwise missed?)

Outcome measures

Measure	Primary Care Sites n=6 Sites e.g., private practice, FQHC	Specialty Care Sites n=6 Sites e.g., pulmonary, asthma/immunology	Novelty Care Site n=1 Sites e.g., telehealth component of Allergy and Asthma Network	Total n=13 Sites All sites
Percentage Endorsement of Responses by Site HCPs for the Categorical Item on the Post-study Survey Relating to Whether the AIRQ Helped Identify Patients at Risk for Adverse Asthma Health Outcomes Yes	5 Sites	3 Sites	1 Sites	9 Sites
Percentage Endorsement of Responses by Site HCPs for the Categorical Item on the Post-study Survey Relating to Whether the AIRQ Helped Identify Patients at Risk for Adverse Asthma Health Outcomes No	1 Sites	3 Sites	0 Sites	4 Sites

PRIMARY outcome

Timeframe: Post-study survey was completed between 5 weeks and 50.6 weeks of last patient end of follow-up across sites; end of follow up was 36 weeks from last patient enrolled at site (or 6 weeks for the novel care site).

Population: Number of site HCPs who responded to the post-study HCP survey (one HCP responded per site)

The post-study HCP survey includes questions regarding the implementation of the PRECISION program at the site (e.g., What did you find most useful about AIRQ?)

Outcome measures

Measure	Primary Care Sites n=6 Sites e.g., private practice, FQHC	Specialty Care Sites n=6 Sites e.g., pulmonary, asthma/immunology	Novelty Care Site n=1 Sites e.g., telehealth component of Allergy and Asthma Network	Total n=13 Sites All sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Most and Least Helpful Parts of AIRQ What did you find most useful about AIRQ? · Total AIRQ® score	4 Sites	1 Sites	1 Sites	6 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Most and Least Helpful Parts of AIRQ What did you find most useful about AIRQ? · Questions on impact/impairment (#1-6)	2 Sites	0 Sites	0 Sites	2 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Most and Least Helpful Parts of AIRQ What did you find most useful about AIRQ? · Question on control (#7)	0 Sites	0 Sites	0 Sites	0 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Most and Least Helpful Parts of AIRQ What did you find most useful about AIRQ? · Questions on exacerbations and healthcare resource utilization (#8-10)	0 Sites	5 Sites	0 Sites	5 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Most and Least Helpful Parts of AIRQ What did you find least useful about AIRQ? · Total AIRQ® score	0 Sites	0 Sites	0 Sites	0 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Most and Least Helpful Parts of AIRQ What did you find least useful about AIRQ? · Questions on impact/impairment (#1-6)	0 Sites	4 Sites	0 Sites	4 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Most and Least Helpful Parts of AIRQ What did you find least useful about AIRQ? · Question on control (#7)	2 Sites	2 Sites	0 Sites	4 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Most and Least Helpful Parts of AIRQ What did you find least useful about AIRQ? · Questions on exacerbations and healthcare resource utilization (#8-10)	4 Sites	0 Sites	1 Sites	5 Sites

PRIMARY outcome

Timeframe: Post-study survey was completed between 5 weeks and 50.6 weeks of last patient end of follow-up across sites; end of follow up was 36 weeks from last patient enrolled at site (or 6 weeks for the novel care site).

Population: Number of site HCPs who responded to the post-study HCP survey (one HCP responded per site)

The post-study HCP survey includes questions regarding the implementation of the PRECISION program at the site (e.g., While using AIRQ how often did you refer to a specialist or practice type different than your own?)

Outcome measures

Measure	Primary Care Sites n=6 Sites e.g., private practice, FQHC	Specialty Care Sites n=6 Sites e.g., pulmonary, asthma/immunology	Novelty Care Site n=1 Sites e.g., telehealth component of Allergy and Asthma Network	Total n=13 Sites All sites
Percentage Endorsement of Responses by Site HCPs for the Categorical Item on the Post-study Survey Relating to Frequency of Referring to a Specialist or Practice Type Different Than Their Own While Using the AIRQ No different than if I did not have the tools	2 Sites	6 Sites	1 Sites	9 Sites
Percentage Endorsement of Responses by Site HCPs for the Categorical Item on the Post-study Survey Relating to Frequency of Referring to a Specialist or Practice Type Different Than Their Own While Using the AIRQ More often than before	4 Sites	0 Sites	0 Sites	4 Sites
Percentage Endorsement of Responses by Site HCPs for the Categorical Item on the Post-study Survey Relating to Frequency of Referring to a Specialist or Practice Type Different Than Their Own While Using the AIRQ Less often than before	0 Sites	0 Sites	0 Sites	0 Sites

PRIMARY outcome

Timeframe: Post-study survey was completed between 5 weeks and 50.6 weeks of last patient end of follow-up across sites; end of follow up was 36 weeks from last patient enrolled at site (or 6 weeks for the novel care site).

Population: Number of site HCPs who responded to the post-study HCP survey (one HCP responded per site)

The post-study HCP survey includes questions regarding the implementation of the PRECISION program at the site (e.g., Did AIRQ improve any of the following?)

Outcome measures

Measure	Primary Care Sites n=6 Sites e.g., private practice, FQHC	Specialty Care Sites n=6 Sites e.g., pulmonary, asthma/immunology	Novelty Care Site n=1 Sites e.g., telehealth component of Allergy and Asthma Network	Total n=13 Sites All sites
Percentage Endorsement of Responses by Site HCPs for the Categorical Item on the Post-study Survey Relating to Components of Care Improved by AIRQ Improved efficiency of in-person asthma clinic visit	2 Sites	1 Sites	0 Sites	3 Sites
Percentage Endorsement of Responses by Site HCPs for the Categorical Item on the Post-study Survey Relating to Components of Care Improved by AIRQ Increased recognition of patients whose asthma placed their health at risk	4 Sites	4 Sites	1 Sites	9 Sites
Percentage Endorsement of Responses by Site HCPs for the Categorical Item on the Post-study Survey Relating to Components of Care Improved by AIRQ Increased recognition of conditions/risks, comorbidities driving poor asthma control	5 Sites	1 Sites	0 Sites	6 Sites
Percentage Endorsement of Responses by Site HCPs for the Categorical Item on the Post-study Survey Relating to Components of Care Improved by AIRQ Improved recognition of patient goals	3 Sites	3 Sites	1 Sites	7 Sites
Percentage Endorsement of Responses by Site HCPs for the Categorical Item on the Post-study Survey Relating to Components of Care Improved by AIRQ Improved patient engagement with their treatment, risk, or control	5 Sites	4 Sites	1 Sites	10 Sites
Percentage Endorsement of Responses by Site HCPs for the Categorical Item on the Post-study Survey Relating to Components of Care Improved by AIRQ Improved efficiency of patient telehealth visit	2 Sites	2 Sites	0 Sites	4 Sites
Percentage Endorsement of Responses by Site HCPs for the Categorical Item on the Post-study Survey Relating to Components of Care Improved by AIRQ Increased educational efforts	6 Sites	3 Sites	1 Sites	10 Sites

PRIMARY outcome

Timeframe: Post-study survey was completed between 5 weeks and 50.6 weeks of last patient end of follow-up across sites; end of follow up was 36 weeks from last patient enrolled at site (or 6 weeks for the novel care site).

Population: Number of site HCPs who responded to the post-study HCP survey (one HCP responded per site)

The post-study HCP survey includes questions regarding the implementation of the PRECISION program at the site (e.g., How important was it for you to use the Assess component of the Asthma Checklist (page 1) with the AIRQ?).

Outcome measures

Measure	Primary Care Sites n=6 Sites e.g., private practice, FQHC	Specialty Care Sites n=6 Sites e.g., pulmonary, asthma/immunology	Novelty Care Site n=1 Sites e.g., telehealth component of Allergy and Asthma Network	Total n=13 Sites All sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Importance of Using Different Components of the PRECISION Program How important was it for you to use the Assess component of the Asthma Checklist with the AIRQ? · Very important	4 Sites	0 Sites	0 Sites	4 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Importance of Using Different Components of the PRECISION Program How important was it for you to use the Assess component of the Asthma Checklist with the AIRQ? · Somewhat important	2 Sites	5 Sites	1 Sites	8 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Importance of Using Different Components of the PRECISION Program How important was it for you to use the Assess component of the Asthma Checklist with the AIRQ? · Not at all important	0 Sites	1 Sites	0 Sites	1 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Importance of Using Different Components of the PRECISION Program How important was it for you to use the Assess component of the Asthma Checklist with the AIRQ? · Did not use	0 Sites	0 Sites	0 Sites	0 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Importance of Using Different Components of the PRECISION Program How important was it for you to use the Adjust and Review components of the Asthma Checklist? · Very important	3 Sites	0 Sites	0 Sites	3 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Importance of Using Different Components of the PRECISION Program How important was it for you to use the Adjust and Review components of the Asthma Checklist? · Somewhat important	2 Sites	5 Sites	1 Sites	8 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Importance of Using Different Components of the PRECISION Program How important was it for you to use the Adjust and Review components of the Asthma Checklist? · Not at all important	0 Sites	0 Sites	0 Sites	0 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Importance of Using Different Components of the PRECISION Program How important was it for you to use the Adjust and Review components of the Asthma Checklist? · Did not use	1 Sites	1 Sites	0 Sites	2 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Importance of Using Different Components of the PRECISION Program How important would it be for PCPs to use the Asthma Checklist Assess component with the AIRQ? · Very important	5 Sites	3 Sites	1 Sites	9 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Importance of Using Different Components of the PRECISION Program How important would it be for PCPs to use the Asthma Checklist Assess component with the AIRQ? · Somewhat important	1 Sites	3 Sites	0 Sites	4 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Importance of Using Different Components of the PRECISION Program How important would it be for PCPs to use the Asthma Checklist Assess component with the AIRQ? · Not at all important	0 Sites	0 Sites	0 Sites	0 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Importance of Using Different Components of the PRECISION Program How important would it be for PCPs to use the Asthma Checklist Assess component with the AIRQ? · Did not use	0 Sites	0 Sites	0 Sites	0 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Importance of Using Different Components of the PRECISION Program How important would it be for Specialists to use Asthma Checklist Adjust/Review pages with AIRQ? · Very important	2 Sites	1 Sites	0 Sites	3 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Importance of Using Different Components of the PRECISION Program How important would it be for Specialists to use Asthma Checklist Adjust/Review pages with AIRQ? · Somewhat important	3 Sites	4 Sites	1 Sites	8 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Importance of Using Different Components of the PRECISION Program How important would it be for Specialists to use Asthma Checklist Adjust/Review pages with AIRQ? · Not at all important	0 Sites	1 Sites	0 Sites	1 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Importance of Using Different Components of the PRECISION Program How important would it be for Specialists to use Asthma Checklist Adjust/Review pages with AIRQ? · Did not use	1 Sites	0 Sites	0 Sites	1 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Importance of Using Different Components of the PRECISION Program How important would it be for Non-prescribers to use Asthma Checklist Assess component with AIRQ? · Very important	3 Sites	3 Sites	0 Sites	6 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Importance of Using Different Components of the PRECISION Program How important would it be for Non-prescribers to use Asthma Checklist Assess component with AIRQ? · Somewhat important	3 Sites	3 Sites	1 Sites	7 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Importance of Using Different Components of the PRECISION Program How important would it be for Non-prescribers to use Asthma Checklist Assess component with AIRQ? · Not at all important	0 Sites	0 Sites	0 Sites	0 Sites
Percentage Endorsement of Responses by Site HCPs for Each Categorical Item on the Post-study Survey Relating to Importance of Using Different Components of the PRECISION Program How important would it be for Non-prescribers to use Asthma Checklist Assess component with AIRQ? · Did not use	0 Sites	0 Sites	0 Sites	0 Sites

PRIMARY outcome

Timeframe: Post-study survey was completed between 5 weeks and 50.6 weeks of last patient end of follow-up across sites; end of follow up was 36 weeks from last patient enrolled at site (or 6 weeks for the novel care site).

Population: Number of site HCPs who responded to the post-study HCP survey (one HCP responded per site)

The post-study HCP survey asks sites to report the number of patients treated using the PRECISION program at their site. One HCP per site reported on the number of patients treated using the PRECISION program at their site. The mean presented is the number of patients at each site as reported by site HCPs divided by the number of sites.

Outcome measures

Measure	Primary Care Sites n=6 Sites e.g., private practice, FQHC	Specialty Care Sites n=6 Sites e.g., pulmonary, asthma/immunology	Novelty Care Site n=1 Sites e.g., telehealth component of Allergy and Asthma Network	Total n=13 Sites All sites
Average Number of Patients Treated Using the PRECISION Program at Each Site as Reported by Site HCPs by Site Type	72.2 Patients per site Standard Deviation 25.9	46.2 Patients per site Standard Deviation 35.5	130.0 Patients per site Standard Deviation NA There is no standard deviation because there is only 1 site	64.6 Patients per site Standard Deviation 36.9

PRIMARY outcome

Timeframe: Post-study survey was completed between 32.9 weeks and 50.6 weeks of last patient end of follow-up across sites; end of follow up was 36 weeks from last patient enrolled at site.

Population: Number of primary care site HCPs who responded to the post-study HCP survey (one HCP responded for each site)

On the post-study survey, one HCP per site (site PI) was asked to describe the features of the PRECISION program they thought were the most useful and could be improved when implemented at their site

Outcome measures

Measure	Primary Care Sites n=6 Sites e.g., private practice, FQHC	Specialty Care Sites e.g., pulmonary, asthma/immunology	Novelty Care Site e.g., telehealth component of Allergy and Asthma Network	Total All sites
Descriptive Free-text Site HCP Responses to Open-ended Question on Post-study Survey on Features of PRECISION Program: Primary Care Sites Most useful features: Helped bring asthma and asthma control to the forefront	2 Sites	—	—	—
Descriptive Free-text Site HCP Responses to Open-ended Question on Post-study Survey on Features of PRECISION Program: Primary Care Sites Most useful features: Closer attention paid to use of inhalers	2 Sites	—	—	—
Descriptive Free-text Site HCP Responses to Open-ended Question on Post-study Survey on Features of PRECISION Program: Primary Care Sites Most useful features: Improved asthma patient care	2 Sites	—	—	—
Descriptive Free-text Site HCP Responses to Open-ended Question on Post-study Survey on Features of PRECISION Program: Primary Care Sites Most useful features: Provided objective numerical score to discuss with patients	1 Sites	—	—	—
Descriptive Free-text Site HCP Responses to Open-ended Question on Post-study Survey on Features of PRECISION Program: Primary Care Sites Most useful features: Helped patients understand their asthma status	1 Sites	—	—	—
Descriptive Free-text Site HCP Responses to Open-ended Question on Post-study Survey on Features of PRECISION Program: Primary Care Sites Features to be improved: Patient self-completing AIRQ prior to visit, possibly as self-assessment	2 Sites	—	—	—
Descriptive Free-text Site HCP Responses to Open-ended Question on Post-study Survey on Features of PRECISION Program: Primary Care Sites Features to be improved: AIRQ mode of incorporation into workflow	2 Sites	—	—	—
Descriptive Free-text Site HCP Responses to Open-ended Question on Post-study Survey on Features of PRECISION Program: Primary Care Sites Features to be improved: Stylistic features of AIRQ and Asthma checklist	2 Sites	—	—	—
Descriptive Free-text Site HCP Responses to Open-ended Question on Post-study Survey on Features of PRECISION Program: Primary Care Sites Features to be improved: Assess patients not on optimal inhalers due to medication unaffordability	1 Sites	—	—	—

PRIMARY outcome

Timeframe: Post-study survey was completed between 22.1 weeks and 50.4 weeks of last patient end of follow-up across sites; end of follow up was 36 weeks from last patient enrolled at site.

Population: Number of speciality care site HCPs who responded to the post-study HCP survey (one HCP responded per site)

On the post-study survey, one HCP per site (site PI) was asked to describe the features of the PRECISION program they thought were most useful and could be improved when implemented at their site

Outcome measures

Measure	Primary Care Sites n=6 Sites e.g., private practice, FQHC	Specialty Care Sites e.g., pulmonary, asthma/immunology	Novelty Care Site e.g., telehealth component of Allergy and Asthma Network	Total All sites
Descriptive Free-text Site HCP Responses to Open-ended Question on Post-study Survey on Features of PRECISION Program: Specialty Care Sites Most useful features: Improved recognition of asthma control and risk	3 Sites	—	—	—
Descriptive Free-text Site HCP Responses to Open-ended Question on Post-study Survey on Features of PRECISION Program: Specialty Care Sites Most useful features: Ease of administration of AIRQ	2 Sites	—	—	—
Descriptive Free-text Site HCP Responses to Open-ended Question on Post-study Survey on Features of PRECISION Program: Specialty Care Sites Most useful features: Improved recognition of how patients assess their asthma	1 Sites	—	—	—
Descriptive Free-text Site HCP Responses to Open-ended Question on Post-study Survey on Features of PRECISION Program: Specialty Care Sites Most useful features: Patient educational goals	1 Sites	—	—	—
Descriptive Free-text Site HCP Responses to Open-ended Question on Post-study Survey on Features of PRECISION Program: Specialty Care Sites Features to be improved: Ease of implementation in workflow	3 Sites	—	—	—
Descriptive Free-text Site HCP Responses to Open-ended Question on Post-study Survey on Features of PRECISION Program: Specialty Care Sites Features to be improved: More detailed questions on AIRQ	1 Sites	—	—	—
Descriptive Free-text Site HCP Responses to Open-ended Question on Post-study Survey on Features of PRECISION Program: Specialty Care Sites Features to be improved: Redundancy of Asthma Checklist	1 Sites	—	—	—

PRIMARY outcome

Timeframe: Post-study survey was completed 5 weeks after last patient end of follow-up; end of follow up was 6 weeks from last patient enrolled at site.

Population: Number of novel care site HCPs who responded to the post-study HCP survey (one HCP responded per site)

On the post-study survey, one HCP per site (site PI) was asked to describe the features of the PRECISION program they thought were most useful and could be improved when implemented at their site

Outcome measures

Measure	Primary Care Sites n=1 Sites e.g., private practice, FQHC	Specialty Care Sites e.g., pulmonary, asthma/immunology	Novelty Care Site e.g., telehealth component of Allergy and Asthma Network	Total All sites
Descriptive Free-text Site HCP Responses to Open-ended Question on Post-study Survey on Features of PRECISION Program: Novel Care Site Most useful features: Educational resources	1 Sites	—	—	—
Descriptive Free-text Site HCP Responses to Open-ended Question on Post-study Survey on Features of PRECISION Program: Novel Care Site Features to be improved: Adding additional response options for the AIRQ rescue inhaler use question	1 Sites	—	—	—

PRIMARY outcome

Timeframe: Post-study clinician interviews were completed between -2 weeks (interviews completed a little sooner than end of follow-up) and 52.4 weeks of last patient end of follow-up across sites; end of follow up was 36 weeks from last patient enrolled at site.

Population: Number of clinicians from primary care sites who took part in the interviews (more than one clinician per site took part in the interviews)

Site clinicians were asked to respond to several open-ended questions regarding background information about the site, the implementation process at their site, use of the Asthma Checklist and educational resources, and feedback on the entire program.

Outcome measures

Measure	Primary Care Sites n=6 Sites e.g., private practice, FQHC	Specialty Care Sites e.g., pulmonary, asthma/immunology	Novelty Care Site e.g., telehealth component of Allergy and Asthma Network	Total All sites
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Ease of implementation: Difficulty accessing and using the website	2 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Ease of implementation: Additional demands to implement the AIRQ	1 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Barriers to implementation: Busy HCP schedules	6 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Barriers to implementation: Difficulty sharing AIRQ questionnaire in Telehealth visits	3 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Barriers to implementation: COVID-related challenges	2 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Barriers to implementation: Interest in several medical conditions, not just Asthma	1 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Areas for improvement: Ease process of incorporating AIRQ into workflow	3 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Areas for improvement: Facilitate patient access and completion of the AIRQ prior to the visit	3 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Areas for improvement: Incorporate into EMR	4 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Areas for improvement: Support with printing the AIRQ forms in color	2 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Areas for improvement: Improve website to make it more user friendly	1 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Areas for improvement: Translate AIRQ into other languages	1 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Areas for improvement: Allow insurance coverage for time spent administering AIRQ	1 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Benefits: Helped with assessing asthma control and risk	4 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Benefits: Helped optimize care	3 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Benefits: Helped guide treatment decisions	3 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Benefits: Helped improve patient assessment and self-management	4 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Benefits: Providing educational resources was valuable for patient and staff education	3 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Benefits: AIRQ preferred over other screening tools	1 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Benefits: AIRQ score confirmed and reassured patient of need for referral	1 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Benefits: Increased provider and patient accountability for Asthma prevention	1 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Ease of implementation: Easy to use	5 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Ease of implementation: AIRQ questionnaire was quick to complete	1 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Ease of implementation: Patients needing assistance to complete the AIRQ questions	1 Sites	—	—	—

PRIMARY outcome

Timeframe: Post-study key site staff interviews were completed between -2 weeks (interviews completed a little sooner than end of follow-up) and 43 weeks of last patient end of follow-up across sites; end of follow up was 36 weeks from last patient enrolled at site.

Population: Number of key site staff from primary care sites who took part in the interviews (one key site staff per site took part in the interviews)

Key site staff were asked to respond to several open-ended questions regarding background information about the site, the implementation process at their site, use of the Asthma Checklist and educational resources, and feedback on the entire program.

Outcome measures

Measure	Primary Care Sites n=5 Sites e.g., private practice, FQHC	Specialty Care Sites e.g., pulmonary, asthma/immunology	Novelty Care Site e.g., telehealth component of Allergy and Asthma Network	Total All sites
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Benefits: Opened up discussion with patients to improve Asthma care	2 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Benefits: Brought Asthma to the forefront	2 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Benefits: Improved detection of Asthma problems	1 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Benefits: Doing more Asthma action plans	1 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Benefits: Making greater use of pharmacy students to educate and support patients	1 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Ease of implementation: Time added to workflow	4 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Ease of implementation: AIRQ questionnaire straightforward to complete	3 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Ease of implementation: AIRQ questionnaire quick to complete	2 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Ease of implementation: Asthma Checklist difficult to use	2 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Ease of implementation: Need to review AIRQ answers with patients due to incorrect answers	1 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Ease of implementation: Additional demands to implement the AIRQ	1 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Ease of implementation: Need for supplemental readily accessible materials	1 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Ease of implementation: Factors that eased implementation	1 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Barriers to implementation: Rescheduled or cancelled appointments	3 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Barriers to implementation: Busy HCP schedules	2 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Barriers to implementation: AIRQ not presented as part of regular medical visit/workflow	1 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Barriers to implementation: Asthma often trumped by other health concerns	1 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Barriers to implementation: Issues with Asthma patient list	1 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Barriers to implementation: Recommended procedures not always completed in telehealth visits	1 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Barriers to implementation: More difficult to do hands-on teaching in telehealth visits	1 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Areas for improvement: Incorporating AIRQ as part of regular medical visit	1 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Areas for improvement: Incorporating AIRQ in EMR	1 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Areas for improvement: Having an electronic fillable version of the AIRQ	1 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Areas for improvement: Recall period for AIRQ	1 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Areas for improvement: Removing unnecessary questions on AIRQ	1 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Primary Care Sites Areas for improvement: Restructuring the checklist	1 Sites	—	—	—

PRIMARY outcome

Timeframe: Post-study clinician interviews were completed between -6.3 weeks (interviews completed a little sooner than end of follow-up) and 23 weeks of last patient end of follow-up across sites; end of follow up was 36 weeks from last patient enrolled at site.

Population: Number of clinicians from specialty care sites who took part in the interviews (more than one clinician per site took part in the interviews)

Site clinicians were asked to respond to several open-ended interview questions regarding background information about the site, the implementation process at their site, use of the Asthma Checklist and educational resources, and feedback on the entire program.

Outcome measures

Measure	Primary Care Sites n=6 Sites e.g., private practice, FQHC	Specialty Care Sites e.g., pulmonary, asthma/immunology	Novelty Care Site e.g., telehealth component of Allergy and Asthma Network	Total All sites
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Benefits: Helped with assessing asthma control and risk	6 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Benefits: AIRQ preferred by HCP over other screening tools	4 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Benefits: Helped optimize care	3 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Benefits: AIRQ questionnaire guided treatment recommendations	2 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Benefits: AIRQ questionnaire helped improve patient assessment and self-management	2 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Benefits: Comprehensive Asthma management tool	1 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Benefits: AIRQ questionnaire could be used to check on whether a full medical visit is needed	1 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Benefits: Aligns with clinician's approach of assessing Asthma	1 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Ease of implementation: Easy to use	5 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Ease of implementation: Difficulty accessing and using the website	3 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Ease of implementation: AIRQ educational materials too complex for the patient's education level	1 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Barriers to implementation: Busy HCP schedules	3 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Barriers to implementation: Difficulty administering AIRQ questionnaire in Telehealth visits	2 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Barriers to implementation: Not sharing educational resources to not overburden patients	1 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Barriers to implementation: Cannot find a way to implement automated distribution of AIRQ	1 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Barriers to implementation: Difficulty combining additional with existing resources	1 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Barriers to implementation: ACT required by insurance companies to renew biologics; hard to do both	1 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Areas for improvement: Making Asthma Checklist and educational resources more easily accessible	1 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Areas for improvement: Incorporating into the EMR	1 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Areas for improvement: Supporting automated distribution of AIRQ	1 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Areas for improvement: Building AIRQ into an app for automatic notification of Asthma complications	1 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Areas for improvement: Making the educational materials available on an app as opposed to website	1 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Areas for improvement: Making the educational materials easier to understand	1 Sites	—	—	—
Descriptive Free-text Clinician Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Areas for improvement: Would be useful to share the tools with other HCPs	1 Sites	—	—	—

PRIMARY outcome

Timeframe: Post-study site staff interviews were completed between -6.3 weeks (interviews completed a little sooner than end of follow-up) and 4.7 weeks of last patient end of follow-up across sites; end of follow up was 36 weeks from last patient enrolled at site.

Population: Number of key site staff from specialty care sites who took part in the interviews (one key site staff per site took part in the interviews)

Key site staff were asked to respond to several open-ended questions regarding background information about the site, the implementation process at their site, use of the Asthma Checklist and educational resources, and feedback on the entire program.

Outcome measures

Measure	Primary Care Sites n=2 Sites e.g., private practice, FQHC	Specialty Care Sites e.g., pulmonary, asthma/immunology	Novelty Care Site e.g., telehealth component of Allergy and Asthma Network	Total All sites
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Benefits: Great tool to evaluate patients	1 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Ease of implementation: Time consuming process	1 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Ease of implementation: AIRQ questionnaire quick to complete	1 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Ease of implementation: Needing to ensure patients respond correctly to the AIRQ	1 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Barriers to implementation: Ensuring clinicians' schedule was not interrupted when implementing AIRQ	1 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Barriers to implementation: Difficulty transmitting AIRQ results between HCP, patient, site staff	1 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Specialty Care Sites Areas for improvement: Recall period for AIRQ	1 Sites	—	—	—

PRIMARY outcome

Timeframe: Post-study HCP interviews were completed 5 weeks after last patient end of follow-up; end of follow up was 6 weeks from last patient enrolled at site.

Population: Number of HCPs from novel site who took part in the interviews

Site HCPs were asked to respond to several open-ended interview questions regarding background information about the site, the implementation process at their site, use of the Asthma Checklist and educational resources, and feedback on the entire program.

Outcome measures

Measure	Primary Care Sites n=1 Sites e.g., private practice, FQHC	Specialty Care Sites e.g., pulmonary, asthma/immunology	Novelty Care Site e.g., telehealth component of Allergy and Asthma Network	Total All sites
Descriptive Free-text HCP Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Novel Site Benefits: AIRQ tools helped with assessing asthma control and risk	1 Sites	—	—	—
Descriptive Free-text HCP Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Novel Site Benefits: Preferred over other screening tools	1 Sites	—	—	—
Descriptive Free-text HCP Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Novel Site Benefits: Helped optimize care	1 Sites	—	—	—
Descriptive Free-text HCP Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Novel Site Benefits: Providing educational resources post visit was valuable for patient and staff education	1 Sites	—	—	—
Descriptive Free-text HCP Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Novel Site Benefits: Resources were empowering for patients	1 Sites	—	—	—
Descriptive Free-text HCP Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Novel Site Ease of implementation: Easy to use	1 Sites	—	—	—
Descriptive Free-text HCP Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Novel Site Ease of implementation: Quick to complete	1 Sites	—	—	—
Descriptive Free-text HCP Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Novel Site Ease of implementation: Use of infographics	1 Sites	—	—	—
Descriptive Free-text HCP Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Novel Site Ease of implementation: Difficulty using and accessing the website	1 Sites	—	—	—
Descriptive Free-text HCP Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Novel Site Ease of implementation: Difficulty accessing and using the website	1 Sites	—	—	—
Descriptive Free-text HCP Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Novel Site Barriers to implementation: None discussed	0 Sites	—	—	—
Descriptive Free-text HCP Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Novel Site Areas for improvement: Revising question on use of rescue inhaler or nebulizer	1 Sites	—	—	—

PRIMARY outcome

Timeframe: Post-study key site staff interviews were completed 5 weeks after last patient end of follow-up; end of follow up was 6 weeks from last patient enrolled at site.

Population: Number of key site staff from novel site who took part in the interviews

Key site staff were asked to respond to several open-ended questions regarding background information about the site, the implementation process at their site, use of the Asthma Checklist and educational resources, and feedback on the entire program.

Outcome measures

Measure	Primary Care Sites n=1 Sites e.g., private practice, FQHC	Specialty Care Sites e.g., pulmonary, asthma/immunology	Novelty Care Site e.g., telehealth component of Allergy and Asthma Network	Total All sites
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Novel Site Benefits: Great tool to evaluate patients	1 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Novel Site Benefits: Providing educational resources was valuable for patient education	1 Sites	—	—	—
Descriptive Free-text Key Site Staff Responses to the Qualitative Interview Questions on Implementation and Features of the Asthma Precision Program: Novel Site Ease of implementation: Easy to implement in Telehealth visits with other programs	1 Sites	—	—	—

PRIMARY outcome

Timeframe: Month 1 after start of implementation

Population: Number of primary care key site staff who took part in the touchpoints at month 1 (one key site staff per site participated)

At each touchpoint, site staff were asked to respond to questions about the implementation of the PRECISION program (e.g., what aspects of the study implementation are going well for your site?)

Outcome measures

Measure	Primary Care Sites n=2 Sites e.g., private practice, FQHC	Specialty Care Sites e.g., pulmonary, asthma/immunology	Novelty Care Site e.g., telehealth component of Allergy and Asthma Network	Total All sites
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Primary Care Sites (Month 1) Benefits: Improved management of asthma and treatment plan	2 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Primary Care Sites (Month 1) Benefits: Improved ability to discuss asthma history with patients	1 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Primary Care Sites (Month 1) Benefits: Improved documentation of patients' asthma, including triggers and exacerbations	1 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Primary Care Sites (Month 1) Benefits: Helped assess asthma control and risk	2 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Primary Care Sites (Month 1) Benefits: Patients are getting more asthma education through the use of the online resources	1 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Primary Care Sites (Month 1) Ease of implementation: AIRQ questionnaire easily understood by patients	1 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Primary Care Sites (Month 1) Ease of implementation: Challenges accessing website for resources	1 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Primary Care Sites (Month 1) Barriers to implementation: Patients scheduled with doctors in study rather than preferred doctor	1 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Primary Care Sites (Month 1) Barriers to implementation: Staffing issues affecting recruitment into the study	1 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Primary Care Sites (Month 1) Areas of improvement: Adding more pictures to website resources and making them more interactive	1 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Primary Care Sites (Month 1) Areas of improvement: AIRQ wording modified to ensure participants report Asthma-related issues	1 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Primary Care Sites (Month 1) Other: Less actual asthma during study period with COVID masks	1 Sites	—	—	—

PRIMARY outcome

Timeframe: Month 2 after start of implementation

Population: Number of primary care key site staff who took part in the touchpoints at month 2 (one key site staff per site participated)

At each touchpoint, site staff were asked to respond to questions about the implementation of the PRECISION program (e.g., what aspects of the study implementation are going well for your site?)

Outcome measures

Measure	Primary Care Sites n=2 Sites e.g., private practice, FQHC	Specialty Care Sites e.g., pulmonary, asthma/immunology	Novelty Care Site e.g., telehealth component of Allergy and Asthma Network	Total All sites
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Primary Care Sites (Month 2) Benefits: Asthma Checklist allows for a more comprehensive discussion of patient's Asthma	1 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Primary Care Sites (Month 2) Barriers to implementation: No challenges, just working with clinicians to set up study	1 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Primary Care Sites (Month 2) Ease of implementation: Discrepancies between AIRQ exacerbation answers and medical chart	1 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Primary Care Sites (Month 2) Ease of implementation: Wanting to integrate the website more to improve use	1 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Primary Care Sites (Month 2) Ease of implementation: Need to simplify and standardize the execution of the AIRQ	1 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Primary Care Sites (Month 2) Other: Looking into conducting more telehealth visits	1 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Primary Care Sites (Month 2) Other: Opening it up to more providers	1 Sites	—	—	—

PRIMARY outcome

Timeframe: Month 1 after start of implementation

Population: Number of specialty care key site staff who took part in the touchpoints at month 1 (one key site staff per site participated)

At each touchpoint, site staff were asked to respond to questions about the implementation of the PRECISION program (e.g., what aspects of the study implementation are going well for your site?)

Outcome measures

Measure	Primary Care Sites n=2 Sites e.g., private practice, FQHC	Specialty Care Sites e.g., pulmonary, asthma/immunology	Novelty Care Site e.g., telehealth component of Allergy and Asthma Network	Total All sites
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Specialty Care Sites (Month 1) Benefits: AIRQ preferred over ACT by providers; gives additional information	2 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Specialty Care Sites (Month 1) Benefits: Helps follow-up on the low/med/high dose for the inhaled corticosteroids	1 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Specialty Care Sites (Month 1) Benefits: HCPs are engaged and like being involved in patient care	1 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Specialty Care Sites (Month 1) Benefits: Patients prefer the AIRQ scale over the ACT 5-point scale (like Yes/No items)	1 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Specialty Care Sites (Month 1) Ease of implementation: Patients (including adolescents) can easily complete the AIRQ on their own	1 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Specialty Care Sites (Month 1) Ease of implementation: Lead nurse training an additional site coordinator	1 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Specialty Care Sites (Month 1) Barriers to implementation: Website not found to be helpful in specialty care	2 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Specialty Care Sites (Month 1) Barriers to implementation: Issues with Sharepoint	1 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Specialty Care Sites (Month 1) Barriers to implementation: Staffing issues affecting recruitment and administration of AIRQ	1 Sites	—	—	—

PRIMARY outcome

Timeframe: Month 2 after start of implementation

Population: Number of novelty care key site staff who took part in the touchpoints at month 2

At each touchpoint, site staff were asked to respond to questions about the implementation of the PRECISION program (e.g., what aspects of the study implementation are going well for your site?)

Outcome measures

Measure	Primary Care Sites n=1 Sites e.g., private practice, FQHC	Specialty Care Sites e.g., pulmonary, asthma/immunology	Novelty Care Site e.g., telehealth component of Allergy and Asthma Network	Total All sites
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Novel Care Site (Month 2) Benefits: None discussed	0 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Novel Care Site (Month 2) Ease of implementation: AIRQ is easy to implement and very self-explanatory	1 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Novel Care Site (Month 2) Ease of implementation: Graphics of educational materials are helpful for HCPs and patients	1 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Novel Care Site (Month 2) Barriers to implementation: Recruitment slower than expected; patients moving away from telehealth	1 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Novel Care Site (Month 2) Barriers to implementation: Difficult to collect exacerbation history; no access to patient files	1 Sites	—	—	—
Descriptive Free-text Site Staff Responses to the Implementation Touchpoint Questions: Novel Care Site (Month 2) Areas for improvement: Sending participants the AIRQ ahead of the call to ease administration	1 Sites	—	—	—

SECONDARY outcome

Timeframe: Mean (SD) time to follow-up was 3.3 (SD = 1.4) months

Population: Number of patients with a baseline and follow-up visit

AIRQ scores range from 0 to 10, where lower scores indicate more well-controlled asthma

The AIRQ was used for the initial study visit, and a follow-up AIRQ that employs the same 10 questions as the AIRQ but for the 3 risk questions where exacerbation history covers a 3 month look-back period instead of a 12 month look-back period was used for follow-up visits.

Outcome measures

Measure	Primary Care Sites n=145 Participants e.g., private practice, FQHC	Specialty Care Sites n=100 Participants e.g., pulmonary, asthma/immunology	Novelty Care Site n=126 Participants e.g., telehealth component of Allergy and Asthma Network	Total All sites
Change in Patient AIRQ Score From Baseline to Follow-up Visits: Mean and Standard Deviation at Each Visit Baseline AIRQ Score	1.8 Points Standard Deviation 2.15	4.2 Points Standard Deviation 3.15	4.5 Points Standard Deviation 2.89	—
Change in Patient AIRQ Score From Baseline to Follow-up Visits: Mean and Standard Deviation at Each Visit Follow-up AIRQ Score	1.1 Points Standard Deviation 1.84	3.1 Points Standard Deviation 3.35	2.8 Points Standard Deviation 2.56	—

SECONDARY outcome

Timeframe: Mean (SD) time to follow-up was 3.3 (SD = 1.4) months

Population: Number of patients with a baseline and follow-up visit

AIRQ scores range from 0 to 10, where lower scores indicate more well-controlled asthma

The AIRQ was used for the initial study visit, and a follow-up AIRQ that employs the same 10 questions as the AIRQ but for the 3 risk questions where exacerbation history covers a 3 month look-back period instead of a 12 month look-back period was used for follow-up visits.

Outcome measures

Measure	Primary Care Sites n=145 Participants e.g., private practice, FQHC	Specialty Care Sites n=100 Participants e.g., pulmonary, asthma/immunology	Novelty Care Site n=126 Participants e.g., telehealth component of Allergy and Asthma Network	Total All sites
Change in Patient AIRQ Score From Baseline to Follow-up Visits: Mean Difference and Confidence Interval	-0.7 Points Interval -1.0 to -0.4	-1.1 Points Interval -1.55 to -0.67	-1.7 Points Interval -2.2 to -1.28	—

SECONDARY outcome

Timeframe: Mean (SD) time to follow-up was 3.3 (SD = 1.4) months

Population: Number of patients in each AIRQ control level category at follow-up by AIRQ control level category at baseline

AIRQ Control level can be categorized as "well controlled", "not-well controlled" or "very poorly controlled"

The AIRQ was used for the initial study visit, and a follow-up AIRQ that employs the same 10 questions as the AIRQ but for the 3 risk questions where exacerbation history covers a 3 month look-back period instead of a 12 month look-back period was used for follow-up visits.

Outcome measures

Measure	Primary Care Sites n=145 Participants e.g., private practice, FQHC	Specialty Care Sites n=100 Participants e.g., pulmonary, asthma/immunology	Novelty Care Site n=126 Participants e.g., telehealth component of Allergy and Asthma Network	Total All sites
Change in Patient AIRQ Control Level From Baseline to Follow-up Visit Baseline AIRQ control category: Well controlled · Follow-up AIRQ Control Category: Well controlled (0-1)	75 Participants	23 Participants	20 Participants	—
Change in Patient AIRQ Control Level From Baseline to Follow-up Visit Baseline AIRQ control category: Well controlled · Follow-up AIRQ Control Category: Not well controlled (2-4)	4 Participants	0 Participants	2 Participants	—
Change in Patient AIRQ Control Level From Baseline to Follow-up Visit Baseline AIRQ control category: Well controlled · Follow-up AIRQ Control Category: Very poorly controlled (5-10)	2 Participants	1 Participants	1 Participants	—
Change in Patient AIRQ Control Level From Baseline to Follow-up Visit Baseline AIRQ control category: Not well controlled · Follow-up AIRQ Control Category: Well controlled (0-1)	23 Participants	23 Participants	17 Participants	—
Change in Patient AIRQ Control Level From Baseline to Follow-up Visit Baseline AIRQ control category: Not well controlled · Follow-up AIRQ Control Category: Not well controlled (2-4)	18 Participants	9 Participants	16 Participants	—
Change in Patient AIRQ Control Level From Baseline to Follow-up Visit Baseline AIRQ control category: Not well controlled · Follow-up AIRQ Control Category: Very poorly controlled (5-10)	4 Participants	4 Participants	6 Participants	—
Change in Patient AIRQ Control Level From Baseline to Follow-up Visit Baseline AIRQ control category: Very poorly controlled · Follow-up AIRQ Control Category: Well controlled (0-1)	6 Participants	5 Participants	15 Participants	—
Change in Patient AIRQ Control Level From Baseline to Follow-up Visit Baseline AIRQ control category: Very poorly controlled · Follow-up AIRQ Control Category: Not well controlled (2-4)	6 Participants	6 Participants	24 Participants	—
Change in Patient AIRQ Control Level From Baseline to Follow-up Visit Baseline AIRQ control category: Very poorly controlled · Follow-up AIRQ Control Category: Very poorly controlled (5-10)	7 Participants	29 Participants	25 Participants	—

SECONDARY outcome

Timeframe: Baseline

Population: Number of patients who completed the patient web-survey which was optional to patients who took part in the study

The ACE questionnaire includes 8 items each with Likert scale responses (strongly agree, agree, disagree, strongly disagree). Participants completed this measure via a patient web survey.

Outcome measures

Measure	Primary Care Sites n=67 Participants e.g., private practice, FQHC	Specialty Care Sites n=31 Participants e.g., pulmonary, asthma/immunology	Novelty Care Site n=9 Participants e.g., telehealth component of Allergy and Asthma Network	Total All sites
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 1 (The AIRQ helped me discuss my asthma with my health care provider(s).) · Strongly Agree	26 Participants	7 Participants	6 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 1 (The AIRQ helped me discuss my asthma with my health care provider(s).) · Agree	29 Participants	17 Participants	2 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 1 (The AIRQ helped me discuss my asthma with my health care provider(s).) · Disagree	6 Participants	4 Participants	1 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 1 (The AIRQ helped me discuss my asthma with my health care provider(s).) · Strongly Disagree	0 Participants	1 Participants	0 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 1 (The AIRQ helped me discuss my asthma with my health care provider(s).) · Not applicable	1 Participants	0 Participants	0 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 1 (The AIRQ helped me discuss my asthma with my health care provider(s).) · Missing	5 Participants	2 Participants	0 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 2 (I received information about my asthma that helped me better understand my condition.) · Strongly Agree	24 Participants	10 Participants	5 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 2 (I received information about my asthma that helped me better understand my condition.) · Agree	27 Participants	17 Participants	3 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 2 (I received information about my asthma that helped me better understand my condition.) · Disagree	8 Participants	2 Participants	1 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 2 (I received information about my asthma that helped me better understand my condition.) · Strongly Disagree	2 Participants	0 Participants	0 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 2 (I received information about my asthma that helped me better understand my condition.) · Not applicable	1 Participants	0 Participants	0 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 2 (I received information about my asthma that helped me better understand my condition.) · Missing	5 Participants	2 Participants	0 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 3 (I received information about my asthma medications.) · Strongly Agree	21 Participants	10 Participants	6 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 3 (I received information about my asthma medications.) · Agree	23 Participants	15 Participants	1 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 3 (I received information about my asthma medications.) · Disagree	16 Participants	4 Participants	1 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 3 (I received information about my asthma medications.) · Strongly Disagree	1 Participants	0 Participants	0 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 3 (I received information about my asthma medications.) · Not applicable	0 Participants	0 Participants	1 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 3 (I received information about my asthma medications.) · Missing	6 Participants	2 Participants	0 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 4 (My health care providers explained the results of tests that I have taken for my asthma.) · Strongly Agree	20 Participants	12 Participants	4 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 4 (My health care providers explained the results of tests that I have taken for my asthma.) · Agree	16 Participants	12 Participants	1 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 4 (My health care providers explained the results of tests that I have taken for my asthma.) · Disagree	3 Participants	0 Participants	2 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 4 (My health care providers explained the results of tests that I have taken for my asthma.) · Strongly Disagree	0 Participants	0 Participants	1 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 4 (My health care providers explained the results of tests that I have taken for my asthma.) · Not applicable	23 Participants	5 Participants	1 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 4 (My health care providers explained the results of tests that I have taken for my asthma.) · Missing	5 Participants	2 Participants	0 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 5 (I was told the reason why tests for my asthma were ordered.) · Strongly Agree	26 Participants	13 Participants	5 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 5 (I was told the reason why tests for my asthma were ordered.) · Agree	15 Participants	9 Participants	0 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 5 (I was told the reason why tests for my asthma were ordered.) · Disagree	3 Participants	1 Participants	2 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 5 (I was told the reason why tests for my asthma were ordered.) · Strongly Disagree	1 Participants	0 Participants	0 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 5 (I was told the reason why tests for my asthma were ordered.) · Not applicable	17 Participants	6 Participants	2 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 5 (I was told the reason why tests for my asthma were ordered.) · Missing	5 Participants	2 Participants	0 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 6 (I was given information about additional care that I need for my asthma.) · Strongly Agree	21 Participants	12 Participants	5 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 6 (I was given information about additional care that I need for my asthma.) · Agree	23 Participants	9 Participants	0 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 6 (I was given information about additional care that I need for my asthma.) · Disagree	5 Participants	2 Participants	2 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 6 (I was given information about additional care that I need for my asthma.) · Strongly Disagree	0 Participants	0 Participants	0 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 6 (I was given information about additional care that I need for my asthma.) · Not applicable	13 Participants	6 Participants	2 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 6 (I was given information about additional care that I need for my asthma.) · Missing	5 Participants	2 Participants	0 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 7 (I was included in making decisions about my asthma treatment.) · Strongly Agree	38 Participants	18 Participants	5 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 7 (I was included in making decisions about my asthma treatment.) · Agree	20 Participants	11 Participants	2 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 7 (I was included in making decisions about my asthma treatment.) · Disagree	4 Participants	0 Participants	0 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 7 (I was included in making decisions about my asthma treatment.) · Strongly Disagree	0 Participants	0 Participants	1 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 7 (I was included in making decisions about my asthma treatment.) · Not applicable	0 Participants	0 Participants	1 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 7 (I was included in making decisions about my asthma treatment.) · Missing	5 Participants	2 Participants	0 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 8 (Time spent with health care provider(s) today discussing my asthma was better.) · Strongly Agree	22 Participants	9 Participants	4 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 8 (Time spent with health care provider(s) today discussing my asthma was better.) · Agree	34 Participants	11 Participants	3 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 8 (Time spent with health care provider(s) today discussing my asthma was better.) · Disagree	6 Participants	8 Participants	1 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 8 (Time spent with health care provider(s) today discussing my asthma was better.) · Strongly Disagree	0 Participants	0 Participants	0 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 8 (Time spent with health care provider(s) today discussing my asthma was better.) · Not applicable	0 Participants	0 Participants	0 Participants	—
Percentage of Endorsement of Responses for Each of the 8 Categorical Items on the ACE Questionnaire Item 8 (Time spent with health care provider(s) today discussing my asthma was better.) · Missing	5 Participants	3 Participants	1 Participants	—

Adverse Events

Primary Care Sites

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Specialty Care Sites

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Novel Care Sites

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

AstraZeneca Clinical Study Information Center

AstraZeneca

Phone: 1-877-240-9479

Email: information.center@astrazeneca.com

Results disclosure agreements

• Principal investigator is a sponsor employee Receiving party will keep Confidential Information in confidence and will not, at any time during or for ten years after the expiration of this Agreement, without the disclosing party's prior written consent, disclose, publish, disseminate or otherwise make available, any item of Confidential Information to any third party. Receiving party will use the Confidential Information only in connection with performance or receipt of Services, or in the exercise of a right granted under this Agreement.
• Publication restrictions are in place

Restriction type: OTHER